Article
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
Blood - 5 Sept 2013
Gotlib Jason, Maxson Julia E, George Tracy I, Tyner Jeffrey W
Abstract excerpt
Although activation of tyrosine kinase pathways is a shared theme among myeloproliferative neoplasms, the pathogenetic basis of chronic neutrophilic leukemia (CNL) has remained elusive. Recently, we identified high-frequency oncogenic mutations in the granulocyte-colony stimulating factor receptor (CSF3R) in CNL and in some patients with atypical chronic myeloid leukemia. Inhibition of Janus kinase 2 or SRC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
